Considering that ERα is a transcription factor that regulates gene expression in mammary gland development and that its dysregulation is closely associated with breast cancer progression, ERα-dependent target molecules may be associated with aggressive breast cancer progression, and their relationship remains to be elucidated. This evidence concerns the gene ESR1 and breast carcinoma.